BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29738082)

  • 1. Suppression of IKK, but not activation of p53 is responsible for cell death mediated by naturally occurring oxidized tetranortriterpenoid.
    Gupta P; Zaidi AH; Manna SK
    J Cell Biochem; 2018 Aug; 119(8):6828-6841. PubMed ID: 29738082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azadirachtin interacts with retinoic acid receptors and inhibits retinoic acid-mediated biological responses.
    Thoh M; Babajan B; Raghavendra PB; Sureshkumar C; Manna SK
    J Biol Chem; 2011 Feb; 286(6):4690-702. PubMed ID: 21127062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azadirachtin interacts with the tumor necrosis factor (TNF) binding domain of its receptors and inhibits TNF-induced biological responses.
    Thoh M; Kumar P; Nagarajaram HA; Manna SK
    J Biol Chem; 2010 Feb; 285(8):5888-95. PubMed ID: 20018848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression of IKKβ by p53 in arsenite-induced GADD45α accumulation and apoptosis.
    Hu Y; Jin R; Gao M; Xu H; Zou S; Li X; Xing C; Wang Q; Wang H; Feng J; Hu M; Song L
    Oncogene; 2019 Jan; 38(5):731-746. PubMed ID: 30177839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells.
    Priyadarsini RV; Murugan RS; Sripriya P; Karunagaran D; Nagini S
    Free Radic Res; 2010 Jun; 44(6):624-34. PubMed ID: 20429769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents.
    Gupta SC; Prasad S; Reuter S; Kannappan R; Yadav VR; Ravindran J; Hema PS; Chaturvedi MM; Nair M; Aggarwal BB
    J Biol Chem; 2010 Nov; 285(46):35406-17. PubMed ID: 20829362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.
    Dey A; Wong ET; Cheok CF; Tergaonkar V; Lane DP
    Cell Death Differ; 2008 Feb; 15(2):263-73. PubMed ID: 17975552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-kappaB sensitizes to benzyl isothiocyanate-induced antiproliferation in p53-deficient colorectal cancer cells.
    Abe N; Hou DX; Munemasa S; Murata Y; Nakamura Y
    Cell Death Dis; 2014 Nov; 5(11):e1534. PubMed ID: 25412312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation.
    Kawauchi K; Araki K; Tobiume K; Tanaka N
    Biochem Biophys Res Commun; 2008 Jul; 372(1):137-41. PubMed ID: 18477470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
    Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation.
    Kawauchi K; Araki K; Tobiume K; Tanaka N
    Nat Cell Biol; 2008 May; 10(5):611-8. PubMed ID: 18391940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.
    Manna SK; Bose JS; Gangan V; Raviprakash N; Navaneetha T; Raghavendra PB; Babajan B; Kumar CS; Jain SK
    J Biol Chem; 2010 Jul; 285(29):22318-27. PubMed ID: 20472557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IKK-β mediates hydrogen peroxide induced cell death through p85 S6K1.
    Jia CH; Li M; Liu J; Zhao L; Lin J; Lai PL; Zhou X; Zhang Y; Chen ZG; Li HY; Liu AL; Yang CL; Gao TM; Jiang Y; Bai XC
    Cell Death Differ; 2013 Feb; 20(2):248-58. PubMed ID: 22955948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profilin potentiates chemotherapeutic agents mediated cell death via suppression of NF-κB and upregulation of p53.
    Zaidi AH; Raviprakash N; Mokhamatam RB; Gupta P; Manna SK
    Apoptosis; 2016 Apr; 21(4):502-13. PubMed ID: 26842845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profilin-PTEN interaction suppresses NF-κB activation via inhibition of IKK phosphorylation.
    Zaidi AH; Manna SK
    Biochem J; 2016 Apr; 473(7):859-72. PubMed ID: 26787927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6beta-hydroxygedunin from Azadirachta indica. Its potentiation effects with some non-azadirachtin limonoids in neem against lepidopteran larvae.
    Koul O; Multani JS; Singh G; Daniewski WM; Berlozecki S
    J Agric Food Chem; 2003 May; 51(10):2937-42. PubMed ID: 12720374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor.
    Sanda T; Asamitsu K; Ogura H; Iida S; Utsunomiya A; Ueda R; Okamoto T
    Leukemia; 2006 Apr; 20(4):590-8. PubMed ID: 16453001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.